보고서 요약(국문)

개요
전 세계 유방 병변 위치 확인 시장은 2023년 3억 6,387만 달러에 달했으며, 2024년부터 2031년까지 연평균 10.5%의 성장률을 기록하며 2031년에는 7억 9,515만 달러에 이를 것으로 예상됩니다.
유방 병변 위치 확인 방법은 수술 전 절차로, 방사성 동위원소, 자기 추적자, 와이어와 같은 위치 확인 장치를 암이 발견된 부위에 삽입하여 수술적 절제 시 촉진되지 않는 병변의 위치를 파악하는 데 사용됩니다.
유방 병변 위치 확인 절차는 병변의 종류와 위치에 따라 초음파, 자기공명영상(MRI), 유방조영술과 같은 수술 유도 시스템을 사용하여 수행됩니다. 유방 병변의 조기 발견이 증가함에 따라, 정확한 병변 제거를 위해 유방 부분 절제술 및 수술적 생검의 최대 50%에서 위치 확인 절차가 필수적이 되었습니다.

시장 동향: 성장 동력 및 제약 요인
유방암 발병률 증가
여성 유방암 발병률 증가는 유방 병변 위치 확인 방법의 세계 시장 성장을 이끄는 주요 요인입니다. 위치 확인은 외과의사가 수술 중 병변을 정확하게 식별하고 절제할 수 있도록 합니다.
예를 들어, 세계암연구기금(World Cancer Research Fund International)에 따르면 2022년 여성 유방암 신규 환자는 2,296,840명에 달했습니다.
전 세계 모든 국가에서 유방암 환자 수가 증가하고 있으며, 이는 병변 위치 확인의 필요성을 높이고 있습니다. 예를 들어, 중국에는 357,161명 이상의 유방암 환자가 있으며, 미국에는 약 274,375명의 유방암 환자가 있습니다. 따라서 유방암 환자 수의 증가는 시장 성장을 촉진할 수 있습니다.
고비용 첨단 기술
방사성 시드 위치 확인(RSL) 및 자기 시드 위치 확인(MSL)과 같은 첨단 위치 확인 방법은 종종 고가의 특수 장비를 필요로 합니다. 초기 투자 외에도 이러한 기술은 지속적인 유지 보수, 특수 장비 및 재료를 필요로 할 수 있으며, 이는 전체 비용을 증가시킵니다. 이는 의료 서비스 제공자에게 재정적 부담을 줄 수 있습니다.
시장 세분화 분석
전 세계 유방 병변 위치 확인 시장은 방법, 장비 및 지역별로 세분화됩니다.
와이어 유도 위치 확인(WGL) 부문이 시장 점유율을 주도할 것으로 예상됩니다.
와이어 유도 위치 확인은 가장 큰 시장 점유율을 차지하고 있으며 예측 기간 동안에도 주도적인 위치를 유지할 것으로 예상됩니다. 이는 초기부터 확립되어 최종 사용자들 사이에서 높은 채택률을 보이기 때문입니다. 이 위치 확인 기술은 특히 다른 방법으로는 시각화하기 어려운 작거나 어려운 병변의 정확한 위치 확인을 제공합니다.
와이어 유도 위치 확인은 유방 수술을 유도하는 데 널리 사용되는 확립된 접근 방식이며, 오랜 성공 사례를 보유하고 있습니다. 이 시술은 잘 규제되고 있으며 높은 안전성과 효능을 입증하여 지속적인 사용과 채택을 보장합니다. 따라서 위의 요인들이 해당 부문의 시장 점유율을 유지하는 데 기여할 것으로 예상됩니다.

시장 지역별 점유율
북미는 유방 병변 위치 파악 시장에서 상당한 점유율을 차지할 것으로 예상됩니다.
북미는 전 세계 유방 병변 위치 파악 방법 시장에서 상당한 점유율을 차지하고 있으며, 이는 주로 이 지역의 높은 유방암 발병률, 광범위한 환자 기반, 그리고 주요 의료 기업들의 존재와 같은 요인에 기인합니다.
또한, 미국과 같은 선진 지역의 높은 인식 수준, 높은 의료비 지출, 연구 시설 및 연구소의 존재, 이 지역 주요 기업들의 광범위한 연구 활동, 그리고 첨단 의료 기술의 조기 도입은 지역 시장 성장을 견인하는 요인입니다.
예를 들어, 미국 질병통제예방센터(CDC)의 2022년 보고서에 따르면, 2021년 여성 유방암 신규 환자는 272,454명이었고, 2022년에는 42,211명의 여성이 유방암으로 사망했습니다.

또한, 미국 암 협회(American Cancer Society, Inc.)에 따르면 2024년에는 여성에게서 약 310,720건의 침습성 유방암이 새로 진단되고, 약 56,500건의 관상피내암(DCIS)이 새로 진단될 것으로 추정됩니다. 따라서 유방암 발병 건수의 증가는 국소 진단 방법에 대한 수요를 증가시켜 해당 지역이 주도적인 위치를 차지하게 할 것으로 예상됩니다.
시장 세분화
방법별
와이어 유도 위치 추적(WGL)
자기 추적자
전자기 반사체
무선 유도 은폐 병변 위치 추적(ROLL)
방사성 시드 위치 추적(RSL)
기타
유방 생검 마커 위치 추적
기타
장치별
방사성 시드
레이더 반사체
자기 시드
무선 주파수 식별 태그 위치 추적기(RFID)
와이어
코일
기타
지역별
북미
미국
캐나다
멕시코
유럽
독일
영국
프랑스
이탈리아
스페인
기타 유럽
남미
브라질
아르헨티나
기타 남미
아시아 태평양
중국
인도
일본
한국
기타 아시아 태평양
중동 및 아프리카
시장 경쟁 환경
주요 글로벌 업체 이 시장에는 Becton, Dickinson, and Company, Sterylab S.r.l., SOMATEX Medical Technologies GmbH, Argon Medical Devices, Hologic Inc., Cook Medical, Mammotome, Merit Medical Systems, Inc., Theragenics Corporation, Mermaid Medical 등이 포함됩니다.
보고서 구매 이유:
유형, 약물 유형, 투여 경로, 유통 채널 및 지역별 글로벌 유방 병변 위치 확인 시장 세분화를 시각화하고 주요 상업 자산 및 플레이어를 파악하기 위함입니다.
트렌드 분석 및 공동 개발을 통해 사업 기회를 식별할 수 있습니다.
모든 세그먼트를 포함한 유방 병변 위치 확인 시장 수준의 다양한 데이터가 담긴 Excel 데이터 시트가 제공됩니다.
PDF 보고서는 심층적인 질적 인터뷰와 연구를 바탕으로 한 종합적인 분석 결과를 담고 있습니다.
모든 주요 플레이어의 핵심 제품을 포함하는 제품 맵핑이 Excel 파일로 제공됩니다.
글로벌 유방 병변 위치 확인 시장 보고서는 약 53개의 표, 47개의 그림, 176페이지로 구성됩니다.

2024년 목표 고객층
제조업체/구매자
산업 투자자/투자은행가
연구 전문가
신흥 기업

보고서 요약(영어 원문)

Overview
Global Breast Lesion Localization Market reached US$ 363.87 million in 2023 and is expected to reach US$ 795.15 million by 2031, growing at a CAGR of 10.5% during the forecast period 2024-2031.
Breast lesion localization methods are pre-surgical procedures, where localization devices such as radioisotopes, magnetic tracers, and wires are inserted into cancer-detected sites to localize a non-palpable lesion at the time of surgical excision.
Breast Lesion Localization Methods procedure is carried out using surgical guidance systems such as ultrasound, Magnetic Resonance Imaging (MRI), or mammography, depending on the type of lesion and its location. With earlier detection of breast lesions, localization procedures have become necessary in up to 50% of all lumpectomy and surgical biopsy procedures to ensure accurate removal of the target lesion.
Market Dynamics: Drivers & Restraints
Increasing incidence of breast cancer
The increasing incidences of breast cancer among women are the predominant driving factor of the global market for breast lesion localization methods. The localization step ensures that the surgeon can accurately identify and excise the lesion during the surgery.
For instance, according to the World Cancer Research Fund International, it is stated that there were 2,296,840 new cases of breast cancer in 2022 among women.
Every country contains a large number of breast cancer patients which is raising the need for localization. For instance, China accounts for over 357,161 individuals suffering from breast cancer and the U.S. accounts for almost 274, 375 individuals with breast cancer. Thus, the increasing number of individuals with breast cancer could raise the market growth.
High cost of advanced technologies
Advanced localization approaches, such as radioactive seed localization (RSL) and magnetic seed localization (MSL), often require the use of costly specialized equipment. Beyond the initial investment, these technologies may necessitate ongoing maintenance, specialized equipment, and materials, which increases the entire cost. This may cause a financial burden on healthcare providers.
Market Segment Analysis
The global breast lesion localization market is segmented based on method, devices and region.
Wire-Guided Localization (WGL) segment is expected to dominate the market share
The wire-guided localization share holds the most significant market share and is expected to remain dominant over the forecast period. It can be attributed to its early establishment and higher adoption rate among end-users. This localization provides precise localization of lesions, especially lesions that are tiny or difficult to visualize using other methods.
Wire-guided localization is a well-established and commonly used approach for directing breast surgery, with a long history of success. The procedure is well-regulated and has a high safety and efficacy profile, which helps to ensure its continued use and adoption. Thus, the above factors are expected to hold the segment in the market share.
Market Geographical Share
North America is expected to hold a significant position in the breast lesion localization market share
North America holds a substantial share of the global breast lesion localization methods market, and it is primarily attributed to factors such as the high prevalence of breast cancer in the region. It has a broad base of the patient population and the presence of significant medical companies.
Moreover, the higher awareness in developed areas such as the U.S., high healthcare expenditure, the presence of research facilities and labs, the extensive research activities undertaken by a majority of prominent players in the area, and the early adoption of advanced medical technologies help propel the regional market.
For instance, according to the Centers for Disease Control and Prevention report in 2022, 272,454 new breast cancers were reported in females in 2021, and in 2022, 42,211 females died from breast cancer.
Additionally, according to the American Cancer Society, Inc., it is estimated that about 310,720 new cases of invasive breast cancer will be diagnosed in women in 2024, and about 56,500 new cases of ductal carcinoma in situ (DCIS) will be diagnosed. Thus, the increasing number of breast cancer cases is expected to increase the demand for localization methods, thus holding the region in the dominant position.
Market Segmentation
By Method
Wire-Guided Localization (WGL)
Magnetic Tracers
Electromagnetic Reflectors
Radio Guided Occult-Lesion Localization (ROLL)
Radioactive-Seed Localization (RSL)
Others
Breast Biopsy Marker Localization
Others
By Devices
Radioactive Seeds
Radar Reflectors
Magnetic Seeds
Radiofrequency Identification Tag Localizers (RFIDs)
Wires
Coils
Others
By Region
North America
The U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Rest of Europe
South America
Brazil
Argentina
Rest of South America
Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
Middle East and Africa
Market Competitive Landscape
The major global players in the market include Becton, Dickinson, and Company, Sterylab S.r.l., SOMATEX Medical Technologies GmbH, Argon Medical Devices, Hologic Inc., Cook Medical, Mammotome, Merit Medical Systems, Inc., Theragenics Corporation and Mermaid Medical among others.
Why Purchase the Report?
To visualize the global breast lesion localization market segmentation based on type, drug type, route of administration, distribution channel, and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of breast lesion localization market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as Excel consisting of key products of all the major players.
The global breast lesion localization market report would provide approximately 53 tables, 47 figures, and 176 pages.
Target Audience 2024
Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Method
3.2. Snippet by Devices
3.3. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing incidence of breast cancer
4.1.1.2. XX
4.1.2. Restraints
4.1.2.1. High cost of advanced technologies
4.1.2.2. XX
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion
6. By Method
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
6.1.2. Market Attractiveness Index, By Method
6.2. Wire-Guided Localization (WGL) *
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Magnetic Tracers
6.4. Electromagnetic Reflectors
6.4.1. Radio Guided Occult-Lesion Localization (ROLL)
6.4.2. Radioactive-Seed Localization (RSL)
6.4.3. Others
6.5. Breast Biopsy Marker Localization
6.6. Others
7. By Devices
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Devices
7.1.2. Market Attractiveness Index, By Devices
7.2. Radioactive Seeds*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Radar Reflectors
7.4. Magnetic Seeds
7.5. Radiofrequency Identification Tag Localizers (RFIDs)
7.6. Wires
7.7. Coils
7.8. Others
8. By Region
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
8.1.2. Market Attractiveness Index, By Region
8.2. North America
8.2.1. Introduction
8.2.2. Key Region-Specific Dynamics
8.2.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
8.2.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Devices
8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.2.3.1. The U.S.
8.2.3.2. Canada
8.2.3.3. Mexico
8.3. Europe
8.3.1. Introduction
8.3.2. Key Region-Specific Dynamics
8.3.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Devices
8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.3.4.1. Germany
8.3.4.2. UK
8.3.4.3. France
8.3.4.4. Italy
8.3.4.5. Spain
8.3.4.6. Rest of Europe
8.4. South America
8.4.1. Introduction
8.4.2. Key Region-Specific Dynamics
8.4.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Devices
8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.4.4.1. Brazil
8.4.4.2. Argentina
8.4.4.3. Rest of South America
8.5. Asia-Pacific
8.5.1. Introduction
8.5.2. Key Region-Specific Dynamics
8.5.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Devices
8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.5.4.1. China
8.5.4.2. India
8.5.4.3. Japan
8.5.4.4. South Korea
8.5.4.5. Rest of Asia-Pacific
8.6. Middle East and Africa
8.6.1. Introduction
8.6.2. Key Region-Specific Dynamics
8.6.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
8.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Devices
9. Competitive Landscape
9.1. Competitive Scenario
9.2. Market Positioning/Share Analysis
9.3. Mergers and Acquisitions Analysis
10. Company Profiles
10.1. Becton, Dickinson, and Company *
10.1.1. Company Overview
10.1.2. Product Portfolio and Description
10.1.3. Financial Overview
10.1.4. Key Developments
10.2. Sterylab S.r.l.
10.3. SOMATEX Medical Technologies GmbH
10.4. Argon Medical Devices
10.5. Hologic Inc.
10.6. Cook Medical
10.7. Mammotome
10.8. Merit Medical Systems, Inc.
10.9. Theragenics Corporation
10.10. Mermaid Medical (*LIST NOT EXHAUSTIVE)
11. Appendix
11.1. About Us and Services
11.2. Contact Us

언급된 주요 기업들

Becton, Dickinson, and Company, 4.	Key Developments, Sterylab S.r.l., SOMATEX Medical Technologies GmbH, Argon Medical Devices, Hologic Inc., Cook Medical, Mammotome, Merit Medical Systems, Inc., Theragenics Corporation

표 목록 (Tables)

List of Tables

Table 1 Global Breast Lesion Localization Methods Market Value, By Method, 2023, 2027 & 2031 (US$ Million)

Table 2 Global Breast Lesion Localization Methods Market Value, By Devices, 2023, 2027 & 2031 (US$ Million)

Table 3 Global Breast Lesion Localization Methods Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 4 Global Breast Lesion Localization Methods Market Value, By Method, 2023, 2027 & 2031 (US$ Million)

Table 5 Global Breast Lesion Localization Methods Market Value, By Method, 2022-2031 (US$ Million)

Table 6 Global Breast Lesion Localization Methods Market Value, By Devices, 2023, 2027 & 2031 (US$ Million)

Table 7 Global Breast Lesion Localization Methods Market Value, By Devices, 2022-2031 (US$ Million)

Table 8 Global Breast Lesion Localization Methods Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 9 Global Breast Lesion Localization Methods Market Value, By Region, 2022-2031 (US$ Million)

Table 10 North America Breast Lesion Localization Methods Market Value, By Method, 2022-2031 (US$ Million)

Table 11 North America Breast Lesion Localization Methods Market Value, By Devices, 2022-2031 (US$ Million)

Table 12 North America Breast Lesion Localization Methods Market Value, By Country, 2022-2031 (US$ Million)

Table 13 Asia-Pacific Breast Lesion Localization Methods Market Value, By Method, 2022-2031 (US$ Million)

Table 14 Asia-Pacific Breast Lesion Localization Methods Market Value, By Devices, 2022-2031 (US$ Million)

Table 15 Asia-Pacific Breast Lesion Localization Methods Market Value, By Country, 2022-2031 (US$ Million)

Table 16 Europe Breast Lesion Localization Methods Market Value, By Method, 2022-2031 (US$ Million)

Table 17 Europe Breast Lesion Localization Methods Market Value, By Devices, 2022-2031 (US$ Million)

Table 18 Europe Breast Lesion Localization Methods Market Value, By Country, 2022-2031 (US$ Million)

Table 19 South America Breast Lesion Localization Methods Market Value, By Method, 2022-2031 (US$ Million)

Table 20 South America Breast Lesion Localization Methods Market Value, By Devices, 2022-2031 (US$ Million)

Table 21 South America Breast Lesion Localization Methods Market Value, By Country, 2022-2031 (US$ Million)

Table 22 Middle East and Africa Breast Lesion Localization Methods Market Value, By Method, 2022-2031 (US$ Million)

Table 23 Middle East and Africa Breast Lesion Localization Methods Market Value, By Devices, 2022-2031 (US$ Million)

Table 24 Middle East and Africa Breast Lesion Localization Methods Market Value, By Country, 2022-2031 (US$ Million)

Table 25 Becton, Dickinson, and Company: Overview

Table 26 Becton, Dickinson, and Company: Product Portfolio

Table 27 Becton, Dickinson, and Company: Key Developments

Table 28 Sterylab S.r.l.: Overview

Table 29 Sterylab S.r.l.: Product Portfolio

Table 30 Sterylab S.r.l.: Key Developments

Table 31 SOMATEX Medical Technologies GmbH: Overview

Table 32 SOMATEX Medical Technologies GmbH: Product Portfolio

Table 33 SOMATEX Medical Technologies GmbH: Key Developments

Table 34 Argon Medical Devices: Overview

Table 35 Argon Medical Devices: Product Portfolio

Table 36 Argon Medical Devices: Key Developments

Table 37 Hologic Inc.: Overview

Table 38 Hologic Inc.: Product Portfolio

Table 39 Hologic Inc.: Key Developments

Table 40 Cook Medical: Overview

Table 41 Cook Medical: Product Portfolio

Table 42 Cook Medical: Key Developments

Table 43 Mammotome: Overview

Table 44 Mammotome: Product Portfolio

Table 45 Mammotome: Key Developments

Table 46 Merit Medical Systems, Inc.: Overview

Table 47 Merit Medical Systems, Inc.: Product Portfolio

Table 48 Merit Medical Systems, Inc.: Key Developments

Table 49 Theragenics Corporation: Overview

Table 50 Theragenics Corporation: Product Portfolio

Table 51 Theragenics Corporation: Key Developments

Table 52 Mermaid Medical: Overview

Table 53 Mermaid Medical: Product Portfolio

Table 54 Mermaid Medical: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Breast Lesion Localization Methods Market Value, 2022-2031 (US$ Million)

Figure 2 Global Breast Lesion Localization Methods Market Share, By Method, 2023 & 2031 (%)

Figure 3 Global Breast Lesion Localization Methods Market Share, By Devices, 2023 & 2031 (%)

Figure 4 Global Breast Lesion Localization Methods Market Share, By Region, 2023 & 2031 (%)

Figure 5 Global Breast Lesion Localization Methods Market Y-o-Y Growth, By Method, 2023-2031 (%)

Figure 6 Wire-Guided Localization (WGL) Breast Lesion Localization Methods Market Value, 2022-2031 (US$ Million)

Figure 7 Magnetic Tracers Breast Lesion Localization Methods Market Value, 2022-2031 (US$ Million)

Figure 8 Electromagnetic Reflectors Breast Lesion Localization Methods Market Value, 2022-2031 (US$ Million)

Figure 9 Breast Biopsy Marker Localization Breast Lesion Localization Methods Market Value, 2022-2031 (US$ Million)

Figure 10 Others Breast Lesion Localization Methods Market Value, 2022-2031 (US$ Million)

Figure 11 Global Breast Lesion Localization Methods Market Y-o-Y Growth, By Devices, 2023-2031 (%)

Figure 12 Radioactive Seeds Devices in Global Breast Lesion Localization Methods Market Value, 2022-2031 (US$ Million)

Figure 13 Radar Reflectors Devices in Global Breast Lesion Localization Methods Market Value, 2022-2031 (US$ Million)

Figure 14 Magnetic Seeds Devices in Global Breast Lesion Localization Methods Market Value, 2022-2031 (US$ Million)

Figure 15 Radiofrequency Identification Tag Localizers (RFIDs) Devices in Global Breast Lesion Localization Methods Market Value, 2022-2031 (US$ Million)

Figure 16 Wires Devices in Global Breast Lesion Localization Methods Market Value, 2022-2031 (US$ Million)

Figure 17 Coils Devices in Global Breast Lesion Localization Methods Market Value, 2022-2031 (US$ Million)

Figure 18 Others Devices in Global Breast Lesion Localization Methods Market Value, 2022-2031 (US$ Million)

Figure 19 Global Breast Lesion Localization Methods Market Y-o-Y Growth, By Region, 2023-2031 (%)

Figure 20 North America Breast Lesion Localization Methods Market Value, 2022-2031 (US$ Million)

Figure 21 North America Breast Lesion Localization Methods Market Share, By Method, 2023 & 2031 (%)

Figure 22 North America Breast Lesion Localization Methods Market Share, By Devices, 2023 & 2031 (%)

Figure 23 North America Breast Lesion Localization Methods Market Share, By Country, 2023 & 2031 (%)

Figure 24 Asia-Pacific Breast Lesion Localization Methods Market Value, 2022-2031 (US$ Million)

Figure 25 Asia-Pacific Breast Lesion Localization Methods Market Share, By Method, 2023 & 2031 (%)

Figure 26 Asia-Pacific Breast Lesion Localization Methods Market Share, By Devices, 2023 & 2031 (%)

Figure 27 Asia-Pacific Breast Lesion Localization Methods Market Share, By Country, 2023 & 2031 (%)

Figure 28 Europe Breast Lesion Localization Methods Market Value, 2022-2031 (US$ Million)

Figure 29 Europe Breast Lesion Localization Methods Market Share, By Method, 2023 & 2031 (%)

Figure 30 Europe Breast Lesion Localization Methods Market Share, By Devices, 2023 & 2031 (%)

Figure 31 Europe Breast Lesion Localization Methods Market Share, By Country, 2023 & 2031 (%)

Figure 32 South America Breast Lesion Localization Methods Market Value, 2022-2031 (US$ Million)

Figure 33 South America Breast Lesion Localization Methods Market Share, By Method, 2023 & 2031 (%)

Figure 34 South America Breast Lesion Localization Methods Market Share, By Devices, 2023 & 2031 (%)

Figure 35 South America Breast Lesion Localization Methods Market Share, By Country, 2023 & 2031 (%)

Figure 36 Middle East and Africa Breast Lesion Localization Methods Market Value, 2022-2031 (US$ Million)

Figure 37 Middle East and Africa Breast Lesion Localization Methods Market Share, By Method, 2023 & 2031 (%)

Figure 38 Middle East and Africa Breast Lesion Localization Methods Market Share, By Devices, 2023 & 2031 (%)

Figure 39 Becton, Dickinson, and Company: Financials

Figure 40 Sterylab S.r.l.: Financials

Figure 41 SOMATEX Medical Technologies GmbH: Financials

Figure 42 Argon Medical Devices: Financials

Figure 43 Hologic Inc.: Financials

Figure 44 Cook Medical: Financials

Figure 45 Mammotome: Financials

Figure 46 Merit Medical Systems, Inc.: Financials

Figure 47 Theragenics Corporation: Financials

Figure 48 Mermaid Medical: Financials

글로벌 유방 병변 위치 파악 방법 시장 – 2024-2031년

Global Breast Lesion Localization Methods Market - 2024-2031